journal article·2013-08Open access

Preparation and evaluations in vitro of oxaliplatin polylactic acid nanoparticles

Zhaoyuan Cui, Yong Sun, Xiaohong Liu, Fang Ju, Qian Chen, Wen Gao, Haitian Wei

Abstract

The oxaliplatin nanoparticles were prepared with polylactic acid matrix, orthogonal test was applied to optimize the prescriptions, and the qualities of oxaliplatin nanoparticles were characterized by the shape, particle size, encapsulation efficiency (EE), and drug loading (DL). Oxaliplatin nanoparticle was prepared by solution replacement method. The formation of 0.25% Tween80, DMF-water 1:8 (v/v), oxaliplatin-polylactic acid 1:5 (w/w), and 20 mg/ml polylactic acid showed the suitable EE (17.4 ± 0.47%), DL (3.52 ± 0.07%). We observed the shape of oxaliplatin nanoparticles through SEM. The average size of the particles was 120.5 ± 8.7 nm, which was detected by N5 submicron particle size analyzer.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Cancer Treatment and Pharmacology · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (10)

Show source-provided references
1. Feng SS · J Control Release · 2001 · 71 · 5310.1016/S0168-3659(00)00364-3 ↗
2. 10.1038/nrd128710.1038/nrd1287 ↗
3. Lee WC · Macromol Biosci · 2006 · 6 · 84610.1002/mabi.200600101 ↗
4. Liu MX · Chem World · 2003 · 44 · 78
5. Lu HX · Beijing Da Xue Xue Bao · 2006 · 38 · 483
6. Mahapatro A · J Nanobiotechnology · 2011 · 9 · 5510.1186/1477-3155-9-55 ↗
7. Mansour HM · Int J Nanomedicine · 2009 · 4 · 29910.2147/IJN.S4937 ↗
8. Matsumura Y · Cancer Res · 1986 · 46 · 6387
9. Vasey PA · Cancer Research Campaign Phase I/II Committee. Clin Cancer Res · 1999 · 5 · 83
10. Yang K · Hua Xi Kou Qiang Yi Xue Za Zhi · 2003 · 21 · 477